Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
  • Rating
    Not Rated
  • Minimum Investment
    5000
  • NAV (Net Asset Value)
    N/A
  • AUM (Fund size)
    25 Cr
  • Created on
    1 May 2021
Fund Ranking
#11
/ 16 in Sectoral-Pharma
Risk Level

Very High

Loading...
Returns
Trailing Return
Rolling Return
  • 6 Month
    11.8%
  • 1 Year
    14.1%
  • 3 Year (CAGR)
    19.8%
  • All Time (CAGR)
    14.0%
Category Return
  • 6 Month
    17.3%
  • 1 Year
    16.6%
  • 3 Year (CAGR)
    20.9%
  • All Time (CAGR)
    17.1%
Asset Allocation
  • Equity
    99.9%
  • Other
    0.1%
Top 5 Holdings
Top 5 Sectors
  • Apollo Hospitals Enterprise
    7.81%
  • Aurobindo Pharma
    3.86%
  • Cipla
    7.33%
  • Dr. Reddy's Laboratories
    8.02%
  • Ipca Laboratories
    2.11%
Fund Information
  • Expense Ratio
    0.44%
  • Exit Load
    No Exit Load
  • Lock-In Period
    No Lock-In

Managed By

Nandik Mallik
March 2026 - Present
Rohit Gautam
March 2026 - Present
Risk & Return Ratio
  • Sharpe Ratio
    0.94
  • Standard Deviation
    16.37
  • Alpha
    -1.18
  • Beta
    0.98